Light-Activated Gel for Diabetic Foot Ulcers
Part of Heart & circulation, Hormones & metabolism, Skin clinical trials.
This trial tests a gel containing a light-activated drug (chlorin E6) for diabetic foot ulcers. The gel is applied to the ulcer and then activated with a special light to help the wound heal. It may be a good option if you have a foot ulcer that hasn't healed in 6 weeks or more.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have type 1 or type 2 diabetes with a foot or lower leg ulcer that has been present for at least 30 days but less than 2 years
- Your blood sugar is reasonably controlled (HbA1c less than 12% and blood sugar less than 350 mg/dL)
- You are not severely infected (no sepsis) and have good blood flow in your leg (ABI between 0.7 and 1.2)
- The ulcer is not too deep (does not reach the bone) and is not on the same foot as another ulcer closer than 3 cm
- You are not pregnant, breastfeeding, or planning to become pregnant, and you have no known allergies to the study gel or related compounds
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new wound gel helps heal diabetic foot ulcers better than the standard gel. It is for people with mild to moderate foot ulcers who have good blood flow and are not taking certain medications.
This trial compares several advanced wound treatments (called CAMPs) plus standard care versus standard care alone for diabetic foot ulcers that are slow to heal. The goal is to see if adding these treatments helps ulcers close faster.
This trial tests a new treatment using special skin cells grown into tiny spheres (spheroids) to help heal diabetic foot ulcers that have not healed with standard care. It aims to see if this treatment is safe and works better than usual care.
This study tests a new wound therapy for diabetic foot ulcers that haven't healed with standard care. It aims to see if the therapy helps these ulcers heal better and faster.
This Phase 3 trial tests ENERGI-F703 gel to help heal diabetic foot ulcers that have not improved for at least 4 weeks. It may help some people whose wounds meet specific size and non-infection criteria.
This study tests a new gel treatment (Nu-3) for mild infections in diabetic foot ulcers. The goal is to find the right dose and see if it helps heal these wounds safely.
Hear when a new Diabetic Foot Ulcer (DFU) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.